Ko Nakashima

Ko Nakashima

Auto-generated profile, based on publicly available information

Ko Nakashima

Japan Small Animal Medical Center Tokorozawa Saitama Japan

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
MNMasaaki Nakamura
Masaaki Nakamura
MTMasashi Takahashi
Masashi Takahashi
KOKoichi Ohno
Koichi Ohno
AKAkiko Koshino
Akiko Koshino
KNKo Nakashima
Ko Nakashima
HTHajime Tsujimoto
Hajime Tsujimoto
To investigate the clinical utility of C-reactive protein (CRP) determination in dogs, its plasma concentration was measured by a laser nephelometric method in 928 dogs with various diseases, and was compared with other inflammatory parameters. CRP concentration was elevated in various inflammatory diseases, this was most frequently observed in cases with neoplastic and immune-mediated diseases. All cases of pyometra, panniculitis, acute pancreatitis, polyarthritis, and hemangiosarcoma showed significantly elevated CRP concentrations. On the other hand, the CRP concentration was elevated only in few cases of neurological diseases such as epilepsy, meningoencephalitis, and hydrocephalus and endocrine diseases such as hypothyroidism, hyperadrenocorticism, and diabetes mellitus. Only a weak correlation was observed between the CRP concentration and white blood cell (WBC) counts (r=0.44) but no correlation with band neutrophil counts. There was no correlation between the CRP and albumin concentrations, but a weak negative correlation (r=-0.40) when excluding chronic intestinal diseases and nephrotic syndrome, which can cause protein loss. Thus, CRP can be useful to detect inflammations that cannot be detected by WBC and, or band neutrophil counts, suggesting that the examination of CRP concentration is essential as routine diagnostic test.

1 July 2015 in The Veterinary Journal
Verified
Journal Article
Closed access
KNK. Nakashima
K. Nakashima
SHS. Hiyoshi
S. Hiyoshi
KOK. Ohno
K. Ohno
KUK. Uchida
K. Uchida
YGY. Goto-Koshino
Y. Goto-Koshino
HTH. Tsujimoto
H. Tsujimoto

23 October 2011 in Veterinary Radiology & Ultrasound
Verified
Journal Article
Closed access
PDF file
TTTaro Tsukagoshi
Taro Tsukagoshi
KOKoichi Ohno
Koichi Ohno
ATAtsushi Tsukamoto
Atsushi Tsukamoto
KFKenjiro Fukushima
Kenjiro Fukushima
MTMasashi Takahashi
Masashi Takahashi
HTHajime Tsujimoto
Hajime Tsujimoto

15 January 2012 in Veterinary Radiology & Ultrasound
Verified
Journal Article
Closed access
PDF file
KFKenjiro Fukushima
Kenjiro Fukushima
HKHideyuki Kanemoto
Hideyuki Kanemoto
KOKoichi Ohno
Koichi Ohno
MTMasashi Takahashi
Masashi Takahashi
KNKo Nakashima
Ko Nakashima
HTHajime Tsujimoto
Hajime Tsujimoto

6 December 2012 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
SMS. Maeda
S. Maeda
KOK. Ohno
K. Ohno
KUK. Uchida
K. Uchida
KNK. Nakashima
K. Nakashima
KFK. Fukushima
K. Fukushima
HTH. Tsujimoto
H. Tsujimoto
Background Although immunoglobulin A (IgA) plays a key role in regulating gut homeostasis, its role in canine inflammatory bowel disease (IBD) is unknown. Hypothesis IgA expression may be altered in dogs with IBD, unlike that observed in healthy dogs and dogs with other gastrointestinal diseases. Animals Thirty‐seven dogs with IBD, 10 dogs with intestinal lymphoma, and 20 healthy dogs. Methods Prospective study. IgA and IgG concentrations in serum, feces, and duodenal samples were measured by ELISA. IgA+ cells in duodenal lamina propria and IgA+ CD21+ peripheral blood mononuclear cells (PBMCs) were examined by immunohistochemistry and flow cytometry, respectively. Duodenal expression of the IgA‐inducing cytokine transforming growth factor β (TGF‐β), B cell activating factor (BAFF), and a proliferation‐inducing ligand (APRIL) was quantified by real‐time RT‐PCR. Results Compared to healthy dogs, dogs with IBD had significantly decreased concentrations of IgA in fecal and duodenal samples. The number of IgA+ CD21+ PBMCs and IgA+ cells in duodenal lamina propria was significantly lower in dogs with IBD than in healthy dogs or dogs with intestinal lymphoma. Duodenal BAFF and APRIL mRNA expression was significantly higher in IBD dogs than in the healthy controls. Duodenal TGF‐β mRNA expression was significantly lower in dogs with IBD than in healthy dogs and dogs with intestinal lymphoma. Conclusions and Clinical Importance IBD dogs have decreased IgA concentrations in feces and duodenum and fewer IgA+ PBMCs, which might contribute to development of chronic enteritis in dogs with IBD.

30 April 2013 in Journal of Veterinary Diagnostic Investigation
Verified
Journal Article
Closed access
PDF file
TTTakashi Tamamoto
Takashi Tamamoto
KOKoichi Ohno
Koichi Ohno
MTMasashi Takahashi
Masashi Takahashi
KNKo Nakashima
Ko Nakashima
YFYasuhito Fujino
Yasuhito Fujino
HTHajime Tsujimoto
Hajime Tsujimoto
Serum amyloid A (SAA) is reported not only as a marker for the presence of inflammation but also as a prognostic indicator in human beings. In cats, however, there is no report on the association between SAA concentration and prognosis. The objective of the current study was to evaluate SAA concentration as a prognostic marker in diseased cats. A total of 175 cats with neoplastic diseases, inflammatory diseases, and other diseases were retrospectively recruited, and the medical records of these cats, including follow-up data on mortality, were reviewed. Cats were divided into 2 groups according to SAA concentration, and differences in survival between each group were assessed. Median survival time of cats in the elevated SAA (>0.82 mg/l) group was significantly shorter than that in the nonelevated SAA (≤0.82 mg/l) group (P < 0.001). Furthermore, by multivariate analysis, SAA concentration was shown as a significant and independent prognostic marker in cats with various diseases (P = 0.015). Serum amyloid A concentration in diseased cats is a useful predictive indicator of prognosis regardless of diagnosis.